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A
t the age of 37, David Baltimore
accomplished what many
researchers dream of but few
achieve: reversing an entrenched
dogma, eventually leading to a new view of
life. In the early 1970s, Baltimore, a member
of the National Academy of Sciences and
a professor of biology at the California In-
stitute of Technology, discovered reverse
transcriptase—an enzyme found in some
tumor viruses whose genetic code is written
in the RNA alphabet. He found that re-
verse transcriptase can copy RNA into
DNA, indicating that some viruses replicate
via a DNA intermediate. The ﬁnding,
which won Baltimore and others the 1975
Nobel Prize in Physiology or Medicine,
enriched biologists’ views on the direction
of ﬂow of genetic information in cells.
Baltimore was the keynote speaker at the
Sackler Colloquium, “Telomerase and
Retrotransposons: Reverse Transcriptases
That Shaped Genomes,” held in September
2010.* Here, he offers PNAS readers his
perspectives on reverse transcription.
PNAS: Researchers are ﬁnding ever more
roles for reverse transcription in cell phys-
iology. Did you envision diverse roles for
the enzyme when you ﬁrst discovered it?
Baltimore: All we knew when we ﬁrst dis-
covered the enzyme was that it was found in
viruses. We had no idea whether there was
any cellular counterpart for the enzymeor if
there was a physiological system that used
reverse transcription. We certainly didn’t
imagine telomerase [a reverse transcriptase
implicated in aging in people]. However,
because reverse transcription is such a fun-
damental biochemical process, we sus-
pected that the enzyme might have other
roles. HIV came along about 10 years later.
PNAS: The discovery of HIV-1 reverse
transcriptase led to antiretroviral therapies
for AIDS. Which other diseases might
become tractable in the coming decades,
thanks to our growing knowledge of reverse
transcription?
Baltimore: We have not found reverse
transcriptases in human disease-causing
retroviruses other than HIV and HTLV.
But there are a number of diseases that
seem to have an infectious component that
we don’t understand. For example, no virus
is unequivocally associated with multiple
sclerosis, but perhaps there’s a retrovirus
hiding there. We just don’t know.
PNAS: Can reverse transcriptases shed light
on evolution?
Baltimore: Reverse transcriptases are a
major evolutionary force. A lot of genome
shaping is a consequence of reverse tran-
scription. Their ability to copy genomic
elements and their mutagenic activity as
they move around the genome make them
important to evolution. Reverse tran-
scriptases can copy messenger RNAs and
reinsert them into the genome as pseudo-
genes. There’s increasing evidence that
pseudogenes affect cellular physiology.
PNAS: The human genome is littered with
what has been labeled “junk DNA,” a great
deal of which seems to be the product of
reverse transcriptases. Do you think these
are largely parasitic DNA sequences?
Baltimore: A lot of the repetitive DNA in
the genome is parasitic. But there is in-
creasing evidence that evolution has
coopted some of that parasitic DNA and
used it to shape the genome. I’ve always
been struck by the fact that some or-
ganisms have very little parasitic DNA
and others have a lot, which suggests
that this DNA might not play a funda-
mental role.
PNAS: You’ve worked on viruses for much
of your career. Has your view of viruses
within the tree of life changed over
the years?
Baltimore: I started in virology before there
was any knowledge of genome sequences.
Viruses were truly a black box. Once the
sequences became available, the ﬁrst thing
that struck us was the differences among
viruses—and the lack of obvious evolu-
tionary links between them. That’s partly
a consequence of the highly mutagenic
nature of viral polymerases, which repli-
cate viruses, and the vast number of rep-
lication cycles that viruses go through over
evolutionary time. Later, when sequence
information for individual viral genes be-
came known, such as the genes in HIV, the
ﬁeld of virology took off. Also, the viral
world continues to expand over time—in
nature and number. Take huge viruses,
like mimiviruses, for example: we could
never really have imagined them before
actually seeing them.
PNAS: Which of the ﬁndings presented at
the 2010 Sackler Symposium, “Telomerase
and Retrotransposons: Reverse Tran-
scriptases That Shaped Genomes,” sur-
prised you the most?
Baltimore: To me, the most surprising
ﬁnding was the structural complexity of
telomerase (1)—especially its RNA. The
enzyme’s recognition capacity and speci-
ﬁcity are so different from those of viral
reverse transcriptases. It was wonderful to
see structural evidence for that.
PNAS: The discovery of reverse transcrip-
tase practically rewrote life’s playbook.
Such game-changing ﬁndings are vanish-
ingly rare in biology. Serendipity aside,
what prepares one for such ﬁndings?
Baltimore: I think it’s the love of discovery.
Starting in the early 1960s, I developed
a tremendous fascination with viruses. I
kept going deeper and deeper into the na-
ture, variety, and ways of viruses. By the
time I discovered reverse transcription, I
was prepared for viruses to do almost any-
thing. In my mind there was no barrier to
thinking about reversing information ﬂow
because we already knew how remarkable
viruses were.
PNAS: Still, you reversed central dogma.
How did that feel?
Baltimore: It felt good. There’s nothing sci-
entists like better than to discover a chink in
the armor of a dogma, particularly one that
has been enshrined in the ﬁeld’s history.
PNAS: You are the sole author of the pub-
lication that showcased your Nobel Prize-
winning discovery. Few single-author pa-
pers get similarly wide acclaim in today’s
collaborative scientiﬁc climate. How do
you feel about this shift in the culture of
scientiﬁc publication?
Baltimore: There are scientiﬁc endeavors
that require large groups of people to work
together, like sequencing, for example. But
at the heart of every great discovery are
usually one or two people. They may have
collaborated with others, but I believe that
great discoveries come from the minds of
individuals. The only counterexample I can
think of is where there are really close col-
laborators likeWatson andCrick, or Brown
and Goldstein. But we treat them as one
individual anyway!
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*The complete program and audio ﬁles of most presen-
tations from this Sackler Colloquium are available on
the NAS Web site at www.nasonline.org/telomerase_and_
retrotransposons, including David Baltimore’s presentation.
Papers arising from the Colloquium are published in the
companion Sackler Special Feature, “Telomerase and Retro-
transposons: Reverse Transcriptases That Shaped Ge-
nomes,” which can be found in this issue of PNAS. Please
refer to the introduction to the Special Feature on page
20304.
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